1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > In Vitro Diagnostics Analysis & Statistics

In Vitro Diagnostics Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

data types

  • All
    • Company Report
1-10 of 10 reports

Coagulation Factor XI - Pipeline Review, H1 2020

  • $ 3500
  • April 2020
  • 69 pages

Coagulation Factor XI - Pipeline Review, H1 2020 Summary According to the recently published report ’Coagulation Factor XI - Pipeline Review, H1 2020’; Coagulation Factor XI (Plasma Thromboplastin ...

  • In Vitro Diagnostics
  • Therapy
  • United States
  • World
  • Bristol-Myers Squibb Company

Coagulation Factor XI - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 70 pages

Coagulation Factor XI - Pipeline Review, H2 2019 Summary Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Factor XI or plasma thromboplastin antecedent is the zymogen ...

  • In Vitro Diagnostics
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 70 pages

Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2019 Summary According to the recently published report ’Plasminogen Activator Inhibitor 1 - Pipeline Review, H2 2019’; Plasminogen Activato ...

  • In Vitro Diagnostics
  • Therapy
  • Transplantation
  • United States
  • Product Initiative

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 61 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H2 2018 Summary Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) pipeline ...

  • In Vitro Diagnostics
  • Therapy
  • United States
  • World
  • Bristol-Myers Squibb Company

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2018

  • $ 3500
  • September 2018
  • 60 pages

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) - Pipeline Review, H2 2018 Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activato ...

  • In Vitro Diagnostics
  • Therapy
  • Transplantation
  • United States
  • Product Initiative

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H1 2018

  • $ 3500
  • March 2018
  • 57 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Pipeline Review, H1 2018 Summary Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Facto ...

  • In Vitro Diagnostics
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018

  • $ 3500
  • March 2018
  • 58 pages

Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activator Inhibitor or PAI1 or SERPINE1) – Pipeline Review, H1 2018 Summary Plasminogen Activator Inhibitor 1 (Endothelial Plasminogen Activato ...

  • General Medicine And Specialty Medicine
  • In Vitro Diagnostics
  • Therapy
  • United States
  • Product Initiative

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2017

  • $ 3500
  • July 2017
  • 33 pages

Tissue Factor Pathway Inhibitor (Extrinsic Pathway Inhibitor or EPI or Lipoprotein Associated Coagulation Inhibitor or LACI or TFPI) - Pipeline Review, H2 2017 Summary Tissue Factor Pathway Inhibito ...

  • In Vitro Diagnostics
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016

  • $ 3500
  • June 2016
  • 53 pages

Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC 3.4.21.27) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Coagulation Factor XI (Plasma Thromboplastin Antecedent or EC ...

  • Coagulation Diagnostic
  • In Vitro Diagnostics
  • United States
  • Product Initiative
  • Bayer AG

Plasminogen Activator Inhibitor-1 (Endothelial Plasminogen Activator Inhibitor or Serpin E1 or PAI-1) - Pipeline Review, H1 2016

  • $ 3500
  • April 2016
  • 60 pages

Plasminogen Activator Inhibitor-1 (Endothelial Plasminogen Activator Inhibitor or Serpin E1 or PAI-1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor-1 ...

  • In Vitro Diagnostics
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on